Mesa Laboratories Q4 revenue rises on SDC growth
Mesa Laboratories Q4 revenue rises on SDC growth
Overview
US life science tools maker's fiscal Q4 revenue rose 2.6% yr/yr
Adjusted operating income excluding unusual items up 49.2% yr/yr, driven by SDC backlog clearance
Company posted net loss for the quarter, citing BPD revenue decline and export delays
Outlook
Mesa expects to provide rest-of-year guidance with H1 results release
Company expects overall revenues to return to positive core organic growth in 1Q27
Result Drivers
SDC BACKLOG CLEARANCE - SDC division revenue growth was driven by reduction of backlog to more normalized levels, improved production, and modest price increases
BPD REVENUE DECLINE - BPD division revenues fell sharply due to commercial execution challenges and shipping delays from export controls
FAVORABLE PRODUCT MIX AND COST ACTIONS - Profitability was supported by favorable product mix and cost realignment actions, offsetting FX and tariff headwinds
Company press release: ID:nGNXS863Q
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 EPS |
| -$0.75 |
|
Q4 Net Income |
| -$4.14 mln |
|
Q4 Basic EPS |
| -$0.75 |
|
Q4 Gross Profit |
| $42.21 mln |
|
Q4 Operating Expenses |
| $39.46 mln |
|
Q4 Operating Income |
| $2.75 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Mesa Laboratories Inc is $104.50, about 1.6% below its May 26 closing price of $106.17
The stock recently traded at 75 times the next 12-month earnings vs. a P/E of 48 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Mesa Laboratories
See all newsMesa Laboratories Inc reports results for the quarter ended March 31 - Earnings Summary
Mesa Laboratories Q4 revenue rises on SDC growth
Brief: Mesa Laboratories Q4 EPS USD -0.75
Brief: Mesa Laboratories Announces CEO Transition And Appointment Of Siddhartha Kadia As President And CEO
Mesa Laboratories Q3 revenue rises 3.6%